Europe Implantable Cardioverter Defibrillator Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By NYHA Class, By End-Use (Hospitals, Ambulatory Surgical Centers), By Country and Growth Forecast, 2023 - 2030

The Europe Implantable Cardioverter Defibrillator Market would witness market growth of 5.7% CAGR during the forecast period (2023-2030).

The implantable cardioverter defibrillator (ICD) is an electronic medical device that monitors and controls cardiac rhythms in patients at risk for life-threatening arrhythmias, such as ventricular tachycardia and ventricular fibrillation. Technological advancements, an escalating incidence of sudden cardiac arrest, a growing public awareness, and supportive government and healthcare policies contribute to the market's expansion. With the increasing prevalence of cardiovascular diseases, it is anticipated that the demand for advanced cardiac care solutions, such as ICDs, will increase, creating opportunities for expansion and innovation in the healthcare industry.

The rising frequency of cardiac diseases and related risk factors, which make sudden cardiac arrest (SCA) deaths a substantial cause of mortality, are predicted to increase the demand for cardiac resynchronization therapy devices (CRT-Ds). A further factor in the need for CRT-Ds is heart failure, a leading cause of death. The increasing incidence of SCA has increased the demand for defibrillators, as survival rates remain low, particularly for out-of-hospital cases. ICDs are essential for patients with abnormal heart rhythms, with a greater prevalence among older individuals with coronary artery disease (CAD).

As per the European Cardiovascular Disease Statistics 2017, cardiovascular disease (CVD) causes over 1.8 million fatalities in the European Union and over 3.9 million deaths in Europe each year. In Europe and the EU, CVD is the primary cause of mortality in 45% and 37% of cases, respectively. CVDs are the leading cause of death in Europe. These diseases encompass various conditions, including coronary artery disease, heart failure, arrhythmias, and others. The prevalence of CVDs varies across European countries but is generally high. Several risk factors contribute to most European CVDs, including smoking, unhealthy dietary habits, physical inactivity, obesity, and excessive alcohol consumption. These risk factors are often modifiable through lifestyle changes and interventions.

The Germany market dominated the Europe Implantable Cardioverter Defibrillator Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $371 million by 2030. The UK market is experiencing a CAGR of 4.8% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 6.5% during (2023 - 2030).

Based on Type, the market is segmented into Biventricular Devices, Dual Chamber ICDs and Single Chamber ICDs. Based on Product Type, the market is segmented into Transvenous and Subcutaneous. Based on NYHA Class, the market is segmented into NYHA Class II and NYHA Class III. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Implantable Cardioverter Defibrillator Market will Hit $5.6 Billion by 2030, at a CAGR of 6.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Biotronik SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Stryker Corporation, ZOLL Medical Corporation (Asahi Kasei Corporation), LivaNova PLC, Koninklijke Philips N.V. and Getinge AB.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Biventricular Devices
• Dual Chamber ICDs
• Single Chamber ICDs

By Product Type

• Transvenous
• Subcutaneous

By NYHA Class

• NYHA Class II
• NYHA Class III

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Medtronic PLC
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• MicroPort Scientific Corporation
• Stryker Corporation
• ZOLL Medical Corporation (Asahi Kasei Corporation)
• LivaNova PLC
• Koninklijke Philips N.V.
• Getinge AB

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Implantable Cardioverter Defibrillator Market, by Type
1.4.2 Europe Implantable Cardioverter Defibrillator Market, by Product Type
1.4.3 Europe Implantable Cardioverter Defibrillator Market, by NYHA Class
1.4.4 Europe Implantable Cardioverter Defibrillator Market, by End-use
1.4.5 Europe Implantable Cardioverter Defibrillator Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Implantable Cardioverter Defibrillator Market

Chapter 5. Europe Implantable Cardioverter Defibrillator Market, By Type
5.1 Europe Biventricular Devices Market, By Country
5.2 Europe Dual Chamber ICDs Market, By Country
5.3 Europe Single Chamber ICDs Market, By Country

Chapter 6. Europe Implantable Cardioverter Defibrillator Market, By Product Type
6.1 Europe Transvenous Market, By Country
6.2 Europe Subcutaneous Market, By Country

Chapter 7. Europe Implantable Cardioverter Defibrillator Market, By NYHA Class
7.1 Europe NYHA Class II Market, By Country
7.2 Europe NYHA Class III Market, By Country

Chapter 8. Europe Implantable Cardioverter Defibrillator Market, By End-use
8.1 Europe Hospitals Market, By Country
8.2 Europe Ambulatory Surgical Centers Market, By Country
8.3 Europe Others Market, By Country

Chapter 9. Europe Implantable Cardioverter Defibrillator Market, By Country
9.1 Germany Implantable Cardioverter Defibrillator Market
9.1.1 Germany Implantable Cardioverter Defibrillator Market, By Type
9.1.2 Germany Implantable Cardioverter Defibrillator Market, By Product Type
9.1.3 Germany Implantable Cardioverter Defibrillator Market, By NYHA Class
9.1.4 Germany Implantable Cardioverter Defibrillator Market, By End-use
9.2 UK Implantable Cardioverter Defibrillator Market
9.2.1 UK Implantable Cardioverter Defibrillator Market, By Type
9.2.2 UK Implantable Cardioverter Defibrillator Market, By Product Type
9.2.3 UK Implantable Cardioverter Defibrillator Market, By NYHA Class
9.2.4 UK Implantable Cardioverter Defibrillator Market, By End-use
9.3 France Implantable Cardioverter Defibrillator Market
9.3.1 France Implantable Cardioverter Defibrillator Market, By Type
9.3.2 France Implantable Cardioverter Defibrillator Market, By Product Type
9.3.3 France Implantable Cardioverter Defibrillator Market, By NYHA Class
9.3.4 France Implantable Cardioverter Defibrillator Market, By End-use
9.4 Russia Implantable Cardioverter Defibrillator Market
9.4.1 Russia Implantable Cardioverter Defibrillator Market, By Type
9.4.2 Russia Implantable Cardioverter Defibrillator Market, By Product Type
9.4.3 Russia Implantable Cardioverter Defibrillator Market, By NYHA Class
9.4.4 Russia Implantable Cardioverter Defibrillator Market, By End-use
9.5 Spain Implantable Cardioverter Defibrillator Market
9.5.1 Spain Implantable Cardioverter Defibrillator Market, By Type
9.5.2 Spain Implantable Cardioverter Defibrillator Market, By Product Type
9.5.3 Spain Implantable Cardioverter Defibrillator Market, By NYHA Class
9.5.4 Spain Implantable Cardioverter Defibrillator Market, By End-use
9.6 Italy Implantable Cardioverter Defibrillator Market
9.6.1 Italy Implantable Cardioverter Defibrillator Market, By Type
9.6.2 Italy Implantable Cardioverter Defibrillator Market, By Product Type
9.6.3 Italy Implantable Cardioverter Defibrillator Market, By NYHA Class
9.6.4 Italy Implantable Cardioverter Defibrillator Market, By End-use
9.7 Rest of Europe Implantable Cardioverter Defibrillator Market
9.7.1 Rest of Europe Implantable Cardioverter Defibrillator Market, By Type
9.7.2 Rest of Europe Implantable Cardioverter Defibrillator Market, By Product Type
9.7.3 Rest of Europe Implantable Cardioverter Defibrillator Market, By NYHA Class
9.7.4 Rest of Europe Implantable Cardioverter Defibrillator Market, By End-use

Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.5.2 Trails and Approvals:
10.1.6 SWOT Analysis
10.2 Medtronic PLC
10.2.1 Company overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 SWOT Analysis
10.3 Biotronik SE & Co. KG
10.3.1 Company Overview
10.3.2 SWOT Analysis
10.4 Boston Scientific Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 SWOT Analysis
10.5 MicroPort Scientific Corporation
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 SWOT Analysis
10.6 Stryker Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.6.6 SWOT Analysis
10.7 ZOLL Medical Corporation (Asahi Kasei Corporation)
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Acquisition and Mergers:
10.7.6 SWOT Analysis
10.8 LivaNova PLC
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.8.5 SWOT Analysis
10.9 Koninklijke Philips N.V.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisition and Mergers:
10.9.6 SWOT Analysis
10.10. Getinge AB
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 SWOT Analysis

TABLE 1 Europe Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 2 Europe Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 3 Europe Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 4 Europe Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 5 Europe Biventricular Devices Market, By Country, 2019 - 2022, USD Million
TABLE 6 Europe Biventricular Devices Market, By Country, 2023 - 2030, USD Million
TABLE 7 Europe Dual Chamber ICDs Market, By Country, 2019 - 2022, USD Million
TABLE 8 Europe Dual Chamber ICDs Market, By Country, 2023 - 2030, USD Million
TABLE 9 Europe Single Chamber ICDs Market, By Country, 2019 - 2022, USD Million
TABLE 10 Europe Single Chamber ICDs Market, By Country, 2023 - 2030, USD Million
TABLE 11 Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 12 Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 13 Europe Transvenous Market, By Country, 2019 - 2022, USD Million
TABLE 14 Europe Transvenous Market, By Country, 2023 - 2030, USD Million
TABLE 15 Europe Subcutaneous Market, By Country, 2019 - 2022, USD Million
TABLE 16 Europe Subcutaneous Market, By Country, 2023 - 2030, USD Million
TABLE 17 Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 18 Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 19 Europe NYHA Class II Market, By Country, 2019 - 2022, USD Million
TABLE 20 Europe NYHA Class II Market, By Country, 2023 - 2030, USD Million
TABLE 21 Europe NYHA Class III Market, By Country, 2019 - 2022, USD Million
TABLE 22 Europe NYHA Class III Market, By Country, 2023 - 2030, USD Million
TABLE 23 Europe Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 24 Europe Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 25 Europe Hospitals Market, By Country, 2019 - 2022, USD Million
TABLE 26 Europe Hospitals Market, By Country, 2023 - 2030, USD Million
TABLE 27 Europe Ambulatory Surgical Centers Market, By Country, 2019 - 2022, USD Million
TABLE 28 Europe Ambulatory Surgical Centers Market, By Country, 2023 - 2030, USD Million
TABLE 29 Europe Others Market, By Country, 2019 - 2022, USD Million
TABLE 30 Europe Others Market, By Country, 2023 - 2030, USD Million
TABLE 31 Europe Implantable Cardioverter Defibrillator Market, By Country, 2019 - 2022, USD Million
TABLE 32 Europe Implantable Cardioverter Defibrillator Market, By Country, 2023 - 2030, USD Million
TABLE 33 Germany Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 34 Germany Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 35 Germany Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 36 Germany Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 37 Germany Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 38 Germany Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 39 Germany Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 40 Germany Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 41 Germany Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 42 Germany Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 43 UK Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 44 UK Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 45 UK Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 46 UK Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 47 UK Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 48 UK Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 49 UK Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 50 UK Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 51 UK Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 52 UK Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 53 France Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 54 France Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 55 France Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 56 France Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 57 France Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 58 France Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 59 France Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 60 France Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 61 France Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 62 France Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 63 Russia Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 64 Russia Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 65 Russia Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 66 Russia Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 67 Russia Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 68 Russia Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 69 Russia Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 70 Russia Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 71 Russia Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 72 Russia Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 73 Spain Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 74 Spain Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 75 Spain Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 76 Spain Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 77 Spain Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 78 Spain Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 79 Spain Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 80 Spain Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 81 Spain Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 82 Spain Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 83 Italy Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 84 Italy Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 85 Italy Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 86 Italy Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 87 Italy Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 88 Italy Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 89 Italy Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 90 Italy Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 91 Italy Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 92 Italy Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 93 Rest of Europe Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
TABLE 94 Rest of Europe Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
TABLE 95 Rest of Europe Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
TABLE 96 Rest of Europe Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
TABLE 97 Rest of Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
TABLE 98 Rest of Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
TABLE 99 Rest of Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
TABLE 100 Rest of Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
TABLE 101 Rest of Europe Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
TABLE 102 Rest of Europe Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
TABLE 103 Key Information – Abbott Laboratories
TABLE 104 Key Information – Medtronic PLC
TABLE 105 Key Information – Biotronik SE & Co. KG
TABLE 106 Key Information – Boston Scientific Corporation
TABLE 107 key Information – MicroPort Scientific Corporation
TABLE 108 Key Information – Stryker Corporation
TABLE 109 Key Information – ZOLL Medical Corporation
TABLE 110 Key Information – LivaNova PLC
TABLE 111 Key Information – Koninklijke Philips N.V.
TABLE 112 Key Information – Getinge AB

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Implantable Cardioverter Defibrillator Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Implantable Cardioverter Defibrillator Market
FIG 4 Porter’s Five Forces Analysis – Implantable Cardioverter Defibrillator Market
FIG 5 Europe Implantable Cardioverter Defibrillator Market share, By Type, 2022
FIG 6 Europe Implantable Cardioverter Defibrillator Market share, By Type, 2030
FIG 7 Europe Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2030, USD Million
FIG 8 Europe Implantable Cardioverter Defibrillator Market share, By Product Type, 2022
FIG 9 Europe Implantable Cardioverter Defibrillator Market share, By Product Type, 2030
FIG 10 Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2030, USD Million
FIG 11 Europe Implantable Cardioverter Defibrillator Market share, By NYHA Class, 2022
FIG 12 Europe Implantable Cardioverter Defibrillator Market share, By NYHA Class, 2030
FIG 13 Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2030, USD Million
FIG 14 Europe Implantable Cardioverter Defibrillator Market share, By End-use, 2022
FIG 15 Europe Implantable Cardioverter Defibrillator Market share, By End-use, 2030
FIG 16 Europe Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2030, USD Million
FIG 17 Europe Implantable Cardioverter Defibrillator Market share, By Country, 2022
FIG 18 Europe Implantable Cardioverter Defibrillator Market share, By Country, 2030
FIG 19 Europe Implantable Cardioverter Defibrillator Market, By Country, 2019 - 2030, USD Million
FIG 20 Recent strategies and developments: ABBOTT LABORATORIES
FIG 21 SWOT Analysis: Abbott Laboratories
FIG 22 SWOT Analysis: Medtronic PLC
FIG 23 SWOT Analysis: Biotronik SE & Co. KG
FIG 24 SWOT Analysis: Boston Scientific Corporation
FIG 25 SWOT Analysis: MicroPort Scientific Corporation
FIG 26 SWOT Analysis: Stryker Corporation
FIG 27 SWOT Analysis: ZOLL Medical Corporation
FIG 28 SWOT Analysis: LivaNova PLC
FIG 29 SWOT Analysis: Koninklijke Philips N.V.
FIG 30 SWOT Analysis: Getinge AB